{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:13:54Z","timestamp":1761948834046},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,16]]},"DOI":"10.7759\/cureus.41959","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T17:11:43Z","timestamp":1689527503000},"source":"Crossref","is-referenced-by-count":3,"title":["The Prospect of Non-Alcoholic Fatty Liver Disease in Adult Patients with Metabolic Syndrome: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Zareen","family":"Zohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ademiniyi","family":"Adelekun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kofi D","family":"Seffah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Korlos","family":"Salib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Dardari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purva","family":"Dahat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy","family":"Toriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Satnarine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana  P","family":"Arcia Franchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo X","year":"2022","unstructured":"Guo X, Yin X, Liu Z, Wang J. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. 2022, 23:15489. 10.3390\/ijms232415489","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes C","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018, 67:123-33. 10.1002\/hep.29466","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2017.08.003","article-title":"The natural history of non-alcoholic fatty liver disease - an evolving view","volume":"22","author":"Lindenmeyer CC","year":"2018","unstructured":"Lindenmeyer CC, McCullough AJ. The natural history of non-alcoholic fatty liver disease - an evolving view. Clin Liver Dis. 2018, 22:11-21.","journal-title":"Clin Liver Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.3","article-title":"Management of NAFLD: a stage-based approach","volume":"13","author":"Rinella ME","year":"2016","unstructured":"Rinella ME, Sanyal AJ. Management of NAFLD: a stage-based approach. Nat Rev Gastroenterol Hepatol. 2016, 13:196-205. 10.1038\/nrgastro.2016.3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels S","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, et al.. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022, 22:63. 10.1186\/s12902-022-00980-1","journal-title":"BMC Endocr Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i42.15539","article-title":"Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Takahashi Y","year":"2014","unstructured":"Takahashi Y, Fukusato T. Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol. 2014, 20:15539-48. 10.3748\/wjg.v20.i42.15539","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson JK","year":"2014","unstructured":"Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014, 5:211-8. 10.1136\/flgastro-2013-100403","journal-title":"Frontline Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-13-40","article-title":"Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets","volume":"13","author":"Giorgio V","year":"2013","unstructured":"Giorgio V, Prono F, Graziano F, Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013, 13:40. 10.1186\/1471-2431-13-40","journal-title":"BMC Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani Y","year":"2017","unstructured":"Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017, 11:215-25. 10.1177\/1753944717711379","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12770","article-title":"Prevalence and association analysis of obstructive sleep apnea with gender and age differences - results of SHIP-Trend","volume":"28","author":"Fietze I","year":"2019","unstructured":"Fietze I, Laharnar N, Obst A, et al.. Prevalence and association analysis of obstructive sleep apnea with gender and age differences - results of SHIP-Trend. J Sleep Res. 2019, 28:e12770. 10.1111\/jsr.12770","journal-title":"J Sleep Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20126","article-title":"Metabolic syndrome and pre-eclampsia","volume":"54","author":"Hooijschuur MC","year":"2019","unstructured":"Hooijschuur MC, Ghossein-Doha C, Kroon AA, De Leeuw PW, Zandbergen AA, Van Kuijk SM, Spaanderman ME. Metabolic syndrome and pre-eclampsia. Ultrasound Obstet Gynecol. 2019, 54:64-71. 10.1002\/uog.20126","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.716159","article-title":"Dietary intake and the development of the metabolic syndrome: the atherosclerosis risk in communities study","volume":"117","author":"Lutsey PL","year":"2008","unstructured":"Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the atherosclerosis risk in communities study. Circulation. 2008, 117:754-61. 10.1161\/CIRCULATIONAHA.107.716159","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4229","article-title":"Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis","volume":"341","author":"Carter P","year":"2010","unstructured":"Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ. 2010, 341:c4229. 10.1136\/bmj.c4229","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults","volume":"21","author":"Pasternak RC","year":"2003","unstructured":"Pasternak RC. Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults. Cardiol Clin. 2003, 21:393-8. 10.1001\/jama.285.19.2486","journal-title":"Cardiol Clin"},{"key":"ref15","article-title":"Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity","volume":"13","author":"Azizi F","year":"2010","unstructured":"Azizi F, Hadaegh F, Khalili D, et al.. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 2010, 13:426-8.","journal-title":"Arch Iran Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy SM","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al.. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112:2735-52. 10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000448940","article-title":"Non-alcoholic fatty liver disease: cause or effect of metabolic syndrome","volume":"32","author":"Grander C","year":"2016","unstructured":"Grander C, Grabherr F, Moschen AR, Tilg H. Non-alcoholic fatty liver disease: cause or effect of metabolic syndrome. Visc Med. 2016, 32:329-34. 10.1159\/000448940","journal-title":"Visc Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15280\/jlm.2015.5.1.7","article-title":"Comorbidities and metabolic derangement of NAFLD","volume":"5","author":"Bang KB","year":"2015","unstructured":"Bang KB, Cho YK. Comorbidities and metabolic derangement of NAFLD. J Lifestyle Med. 2015, 5:7-13. 10.15280\/jlm.2015.5.1.7","journal-title":"J Lifestyle Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/met.2021.0108","article-title":"The association between metabolic syndrome and non-alcoholic fatty liver disease diagnosis varies by race","volume":"20","author":"Mahabaleshwarkar R","year":"2022","unstructured":"Mahabaleshwarkar R, Liu TL, McKillop IH, Spencer M.  The association between metabolic syndrome and non-alcoholic fatty liver disease diagnosis varies by race. Metab Syndr Relat Disord. 2022, 20:286-94. 10.1089\/met.2021.0108","journal-title":"Metab Syndr Relat Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome","volume":"92","author":"Kotronen A","year":"2007","unstructured":"Kotronen A, Westerbacka J, Bergholm R, Pietil\u00e4inen KH, Yki-J\u00e4rvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007, 92:3490-7. 10.1210\/jc.2007-0482","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi M","year":"2005","unstructured":"Hamaguchi M, Kojima T, Takeda N, et al.. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005, 143:722-8. 10.7326\/0003-4819-143-10-200511150-00009","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2174\/1570161115666170621075619","article-title":"Is non-alcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome?","volume":"16","author":"Katsiki N","year":"2018","unstructured":"Katsiki N, Perez-Martinez P, Anagnostis P, Mikhailidis DP, Karagiannis A. Is non-alcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome?. Curr Vasc Pharmacol. 2018, 16:219-27. 10.2174\/1570161115666170621075619","journal-title":"Curr Vasc Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo A","year":"2015","unstructured":"Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. 2015, 47:181-90. 10.1016\/j.dld.2014.09.020","journal-title":"Dig Liver Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008204","article-title":"Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population","volume":"5","author":"Zhang Y","year":"2015","unstructured":"Zhang Y, Zhang T, Zhang C, et al.. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population. BMJ Open. 2015, 5:e008204. 10.1136\/bmjopen-2015-008204","journal-title":"BMJ Open"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani N","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012, 55:2005-23. 10.1002\/hep.25762","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.12.013","article-title":"No clear choice between Newcastle-Ottawa scale and appraisal tool for cross-sectional studies to assess methodological quality in cross-sectional studies of health-related quality of life and breast cancer","volume":"120","author":"Moskalewicz A","year":"2020","unstructured":"Moskalewicz A, Oremus M. No clear choice between Newcastle-Ottawa scale and appraisal tool for cross-sectional studies to assess methodological quality in cross-sectional studies of health-related quality of life and breast cancer. J Clin Epidemiol. 2020, 120:94-103. 10.1016\/j.jclinepi.2019.12.013","journal-title":"J Clin Epidemiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20173703","article-title":"Prevalence of non-alcoholic fatty liver disease in patients of metabolic syndrome in a rural population attending tertiary care centre","volume":"5","author":"Agrawal PK","year":"2017","unstructured":"Agrawal PK, Kumar M, Verma VK, Singh AK, Nim RK, Pious T, Singh PK. Prevalence of non-alcoholic fatty liver disease in patients of metabolic syndrome in a rural population attending tertiary care centre. Int J Res Med Sci. 2017, 5:3898-01. 10.18203\/2320-6012.ijrms20173703","journal-title":"Int J Res Med Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.15171\/mejdd.2016.18","article-title":"The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study","volume":"8","author":"Fattahi MR","year":"2016","unstructured":"Fattahi MR, Niknam R, Safarpour A, Sepehrimanesh M, Lotfi M. The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study. Middle East J Dig Dis. 2016, 8:131-7. 10.15171\/mejdd.2016.18","journal-title":"Middle East J Dig Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1108_19","article-title":"Prevalence of fatty liver in metabolic syndrome","volume":"9","author":"Goyal A","year":"2020","unstructured":"Goyal A, Arora H, Arora S. Prevalence of fatty liver in metabolic syndrome. J Family Med Prim Care. 2020, 9:3246-50. 10.4103\/jfmpc.jfmpc_1108_19","journal-title":"J Family Med Prim Care"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.18535\/jmscr\/v5i6.16","article-title":"Study of patients with non-alcoholic fatty liver disease and its association with metabolic syndrome in tertiary centre","volume":"05","author":"Asati P","year":"2017","unstructured":"Asati P, Kukrele P, Jalodiya S. Study of patients with non-alcoholic fatty liver disease and its association with metabolic syndrome in tertiary centre. J Med Sci Clin Res. 2017, 05:22901-4. 10.18535\/jmscr\/v5i6.16","journal-title":"J Med Sci Clin Res"},{"key":"ref33","article-title":"Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community","volume":"10","author":"Onyekwere CA","year":"2011","unstructured":"Onyekwere CA, Ogbera AO, Balogun BO. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Ann Hepatol. 2011, 10:119-24.","journal-title":"Ann Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos AF","year":"2020","unstructured":"Godoy-Matos AF, Silva J\u00fanior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020, 12:60. 10.1186\/s13098-020-00570-y","journal-title":"Diabetol Metab Syndr"},{"key":"ref35","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with metabolic syndrome","volume":"65","author":"Iftikhar R","year":"2015","unstructured":"Iftikhar R, Kamran S, Sher F, Wahla M. Prevalence of non-alcoholic fatty liver disease in patients with metabolic syndrome.  Pak Armed Forces Med J. 2015, 65:616-9.","journal-title":"Pak Armed Forces Med J"},{"key":"ref36","article-title":"Non-alcoholic fatty liver disease related to metabolic syndrome: a case-control study","volume":"13","author":"Ratnasari N","year":"2012","unstructured":"Ratnasari N, Senorita H, Adie RH, Bayupurnama P, Maduseno S, Nurdjanah S. Non-alcoholic fatty liver disease related to metabolic syndrome: a case-control study.  Indones J Gastroenterol, Hepatol, Dig Endosc. 2012, 13:8-13.","journal-title":"Indones J Gastroenterol, Hepatol, Dig Endosc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2478\/inmed-2019-0052","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease","volume":"16","author":"Gavril OI","year":"2019","unstructured":"Gavril OI, Arhire LL, Mitu O, et al.. Metabolic syndrome and non-alcoholic fatty liver disease. Internal Medicine. 2019, 16:51-8. 10.2478\/inmed-2019-0052","journal-title":"Internal Medicine"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-018-0843-6","article-title":"Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal","volume":"18","author":"Pardhe BD","year":"2018","unstructured":"Pardhe BD, Shakya S, Bhetwal A, et al.. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal. BMC Gastroenterol. 2018, 18:109. 10.1186\/s12876-018-0843-6","journal-title":"BMC Gastroenterol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4099","article-title":"Metabolic syndrome in patients with non-alcoholic fatty liver disease: a community based cross-sectional study","volume":"11","author":"Paudel MS","year":"2019","unstructured":"Paudel MS, Tiwari A, Mandal A, Shrestha B, Kafle P, Chaulagai B, Kc S. Metabolic syndrome in patients with non-alcoholic fatty liver disease: a community based cross-sectional study. Cureus. 2019, 11:e4099. 10.7759\/cureus.4099","journal-title":"Cureus"},{"key":"ref40","article-title":"Non-alcoholic fatty liver disease in metabolic syndrome patients in Serdang hospital: quantification by contrast-enhanced computed tomography","volume":"12","author":"Suppiah S","year":"2016","unstructured":"Suppiah S, Chow LRM, Sazali NSB, Hassan HA. Non-alcoholic fatty liver disease in metabolic syndrome patients in Serdang hospital: quantification by contrast-enhanced computed tomography. Malaysian J Med Heal Sci. 2016, 12:9-18.","journal-title":"Malaysian J Med Heal Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19042096","article-title":"Prevalence and risk factors of metabolic-associated fatty liver disease among 73,566 individuals in Beijing, China","volume":"19","author":"Yuan Q","year":"2022","unstructured":"Yuan Q, Wang H, Gao P, Chen W, Lv M, Bai S, Wu J. Prevalence and risk factors of metabolic-associated fatty liver disease among 73,566 individuals in Beijing, China. Int J Environ Res Public Health. 2022, 19:2096. 10.3390\/ijerph19042096","journal-title":"Int J Environ Res Public Health"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-28032012000100015","article-title":"Metabolic syndrome and risk factors for non-alcoholic fatty liver disease","volume":"49","author":"Souza MR","year":"2012","unstructured":"Souza MR, Diniz Mde F, Medeiros-Filho JE, Ara\u00fajo MS. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol. 2012, 49:89-96. 10.1590\/s0004-28032012000100015","journal-title":"Arq Gastroenterol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.5812\/jjcdc.114541","article-title":"Prevalence of metabolic syndrome and related factors in patients with non-alcoholic fatty liver","volume":"11","author":"Zakerkish M","year":"2021","unstructured":"Zakerkish M, Assarzadeh A, Seyedian SS, Jahanshahi A. Prevalence of metabolic syndrome and related factors in patients with non-alcoholic fatty liver. Jundishapur J Chronic Dis Care. 2021, 11:e114541. 10.5812\/jjcdc.114541","journal-title":"Jundishapur J Chronic Dis Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159359-the-prospect-of-non-alcoholic-fatty-liver-disease-in-adult-patients-with-metabolic-syndrome-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:05Z","timestamp":1707509105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159359-the-prospect-of-non-alcoholic-fatty-liver-disease-in-adult-patients-with-metabolic-syndrome-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,16]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.41959","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,16]]}}}